DocMorris AG (0RRB) Q4 2024 Earnings Call

Investor webinar replay

Replay transcript excerpt

Hello, ladies and gentlemen, and welcome to the DocMorris AG 2020 for full year results and Outlook 2025. At this time, all participants have been placed on a listen-only mode. The floor will be open for questions following the presentation. Let me now turn the floor over to your host, Walter Hess. Yeah, thank you very much and good morning to everybody to today's conference call. The full year results 24 will be presented by Daniel Wurst, our new CFO, and myself. We will share insights and updates across all segments and provide a comprehensive overview of our business performance. So we will start with a business update, followed by a financial update, and conclude with our outlook. Thereafter, we are looking forward to answering your questions. Let us start with the highlights of last year. In 2024, we achieved significant milestones again. Since the introduction of CardLink in April 24, there has been a five-fold increase in new Rx customers. These new customers show significantly improved KPIs compared to our former PRx customers. We are very pleased to announce that in 2024, we reached profitability with our non-Rx business. It reflects our strategic efforts and the successful execution of the breakeven program over the last few years. Overall, there was a 7% increase in revenue with contributions from all business segments. And further, Teleclinic achieved a noteworthy milestone by doubling its revenues, demonstrating strong performance and attractive profitability metrics. And in conclusion, and due to a really effective cash management, we reported a cash balance end of 2024 of 95 million Swiss francs. On slide number five, We look forward to 25 with our strategic initiatives that are centered on, first of all, further expanding RX growth with the customers ...